Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
During early germination, water uptake activates metabolic pathways that stimulate the production of hydrolytic enzymes like ...
For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...
News Medical on MSN
Vitamin A derivative suppresses immune response and cancer vaccine efficacy
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback